Marinus Pharmaceuticals Inc. (Nasdaq: MRNS) extended its losses by losing 76 cents to close at $7.12 as investors continued to lock in profits.
Marinus Pharmaceuticals extends losses
December 18, 2017 at 16:37 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|